At Astria Therapeutics, our team is focused on bringing therapies with the potential to improve the quality of life to patients and families affected by Hereditary Angioedema (HAE) and rare allergic and immunological diseases$1. .$1
11 - 50
💰 $100M Post-IPO Equity on 2022-12
April 5
11 - 50
🇺🇸 United States – Remote
💰 $100M Post-IPO Equity on 2022-12
⏰ Full Time
🟡 Mid-level
🟠 Senior
👷♀️ Project & Program Management
March 12
11 - 50
🇺🇸 United States – Remote
💰 $100M Post-IPO Equity on 2022-12
⏰ Full Time
🟠 Senior
💕 Social Media & Community
January 10
11 - 50
🇺🇸 United States – Remote
💰 $100M Post-IPO Equity on 2022-12
⏰ Full Time
🟡 Mid-level
🟠 Senior
🖥 Software Engineer
December 15, 2023
11 - 50
🇪🇺 Anywhere in Europe – Remote
💰 $100M Post-IPO Equity on 2022-12
⏰ Full Time
🟠 Senior
🧑💻 Full-stack Engineer